We investigated the off-patent biological market in Belgium from a policy maker's perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator's reach and to a concertation model with assessment and appraisal being mixed which results in poorly effective policy measures.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069942 | PMC |
| http://dx.doi.org/10.3390/ph14040352 | DOI Listing |
Publication Analysis
Top Keywords
off-patent biological
8
biological market
8
market belgium
8
health system
8
belgium health
4
system creating
4
creating hurdle
4
hurdle fair
4
fair market
4
market competition?
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!